Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype

Journal of Clinical Investigation

Volumn 121, Issue 11, 2011, Pages 4244-4256

  Li, Jun ^a   Bessho, Kazuhiko ^a   Shivakumar, Pranavkumar ^a   Mourya, Reena ^a   Mohanty, Sujit Kumar ^a   Dos Santos, Jorge L ^b   Miura, Irene K ^c   Porta, Gilda ^c   Bezerra, Jorge A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; STAT6 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT ATRESIA; BONE MARROW CELL; CD4+ CD25+ T LYMPHOCYTE; CELL DAMAGE; CELL DIFFERENTIATION; CELL ISOLATION; CELL POLARITY; CONTROLLED STUDY; EPITHELIAL INJURY; FLOW CYTOMETRY; GENE EXPRESSION; GENE INACTIVATION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN VITRO STUDY; INTRACELLULAR SIGNALING; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ROTAVIRUS INFECTION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRAL CLEARANCE;

ANIMALS; ANIMALS, NEWBORN; BILIARY ATRESIA; CHILD; CHOLESTASIS; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIUM; HUMANS; INTERLEUKIN-13; LIVER; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID CELLS; PHENOTYPE; RNA, MESSENGER; ROTAVIRUS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS;

EID: 80555142900     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57728     Document Type: Article

References (53)

1. Azarow KS, Phillips MJ, Sandler AD, Hagerstrand I, Superina RA. Biliary atresia: should all patients undergo a portoenterostomy? J Pediatr Surg. 1997;32(2):168-172.
2. Pape L, Olsson K, Petersen C, von Wasilewski R, Melter M. Prognostic value of computerized quantification of liver fibrosis in children with biliary atresia. Liver Transpl. 2009;15(8):876-882.
3. Santos JL, et al. The extent of biliary proliferation in liver biopsies from patients with biliary atresia at portoenterostomy is associated with the postoperative prognosis. J Pediatr Surg. 2009;44(4):695-701.
4. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr. 2004;144(1):123-125. (Pubitemid 38091433)
5. Whitington PF. Fortune telling in biliary atresia: what is in the tea leaves? Liver Transpl. 2009;15(8):829-830.
6. Moyer K, et al. Staging of biliary atresia at diagnosis by molecular profiling of the liver. Genome Med. 2010;2(5):33.
7. Bessho K, Bezerra JA. Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med. 2011;62:171-185.
8. Ahmed AF, et al. CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. J Pathol. 2001;193(3):383-389. (Pubitemid 32229872)
9. Bezerra JA, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet. 2002;360(9346):1563-1659.
10. Broome U, Nemeth A, Hultcrantz R, Scheynius A. Different expression of HLA-DR and ICAM-1 in livers from patients with biliary atresia and Byler's disease. J Hepatol. 1997;26(4):857-862. (Pubitemid 27145710)
11. Davenport M, et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg. 2001;36(7):1017-1025. (Pubitemid 32619749)
12. Dillon PW, Belchis D, Minnick K, Tracy T. Differential expression of the major histocompatibility antigens and ICAM-1 on bile duct epithelial cells in biliary atresia. Tohoku J Exp Med. 1997;181(1):33-40. (Pubitemid 127470685)
13. Mack CL, et al. Oligoclonal expansions of CD4+ and CD8+ T-cells in the target organ of patients with biliary atresia. Gastroenterology. 2007;133(1):278-287. (Pubitemid 47031131)
14. Mack CL, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004;56(1):79-87. (Pubitemid 38808546)
15. Shivakumar P, Sabla GE, Whitington P, Chougnet CA, Bezerra JA. Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia. J Clin Invest. 2009;119(8):2281-2290.
16. Petersen C, Kuske M, Bruns E, Biermanns D, Wussow PV, Mildenberger H. Progress in developing animal models for biliary atresia. Eur J Pediatr Surg. 1998;8(3):137-141. (Pubitemid 28312048)
17. Riepenhoff-Talty M, et al. Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res. 1993;33(4 pt 1):394-399. (Pubitemid 23095773)
18. Shivakumar P, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest. 2004;114(3):322-329. (Pubitemid 39071604)
19. Shivakumar P, et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology. 2007;133(1):268-277. (Pubitemid 47031130)
20. Mohanty SK, Shivakumar P, Sabla G, Bezerra JA. Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia. BMC Gastroenterol. 2006;6:14.
21. Gavrilescu LC, Butcher BA, Del Rio L, Taylor GA, Denkers EY. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection. Infect Immun. 2004;72(3):1257-1264. (Pubitemid 38263743)
22. Carvalho E, Liu C, Shivakumar P, Sabla G, Aronow B, Bezerra JA. Analysis of the Biliary Transcriptome in Experimental Biliary Atresia. Gastroenterology. 2005;129(2):713-717. (Pubitemid 41096655)
23. Shivakumar P, Bezerra JA. Biliary atresia and Th1 function: linking lymphocytes and bile ducts: commentary on the article by Mack et al. on page 79. Pediatr Res. 2004;56(1):9-10. (Pubitemid 38808536)
24. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity. 2005;23(4):344-346. (Pubitemid 41443435)
25. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3(1):23-35. (Pubitemid 37328697)
26. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23(11):549-555. (Pubitemid 35223554)
27. Moritoki Y, et al. B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis. Cell Immunol. 2011;268(1):16-23.
28. Ribechini E, Greifenberg V, Sandwick S, Lutz MB. Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol. 2010;199(3):273-281.
29. Yang GX, et al. CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease. J Immunol. 2011;186(2):1259-1267.
30. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174(1-2):83-93.
31. Reyes JL, Terrazas CA, Alonso-Trujillo J, van Rooijen N, Satoskar AR, Terrazas LI. Early removal of alternatively activated macrophages leads to Taenia crassiceps cysticercosis clearance in vivo. Int J Parasitol. 2010;40(6):731-742.
32. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 1996;4(3):313-319. (Pubitemid 26132509)
33. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557-1569.
34. Schmitz J, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479-490. (Pubitemid 41587888)
35. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis. 2007;27(3):233-242. (Pubitemid 47301763)
36. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology. 2007;46(2):566-581. (Pubitemid 47344793)
37. Lichtman AH, Chin J, Schmidt JA, Abbas AK. Role of interleukin 1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A. 1988;85(24):9699-9703. (Pubitemid 19027192)
38. Diehl S, Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002;39(9):531-536. (Pubitemid 35341492)
39. Shang XZ, et al. Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7). Am J Pathol. 2002;161(1):257-266.
40. Lu BR, Brindley SM, Tucker RM, Lambert CL, Mack CL. alpha-enolase autoantibodies cross-reactive to viral proteins in a mouse model of biliary atresia. Gastroenterology. 2010;139(5):1753-1761.
41. Zornetzer GA, et al. Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J Virol. 2010;84(21):11297-11309.
42. Coutinho HM, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis. 2007;195(2):288-295. (Pubitemid 46080061)
43. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leuk Biol. 2008;83(6):1323-1333. (Pubitemid 351960310)
44. Wills-Karp M, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998;282(5397):2258-2261. (Pubitemid 29004074)
45. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425-456. (Pubitemid 37174537)
46. Harris J, et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity. 2007;27(3):505-517. (Pubitemid 47418681)
47. Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol. 2003;111(4):677-690. (Pubitemid 36470232)
48. Chiaramonte MG, et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med. 2003;197(6):687-701. (Pubitemid 36350864)
49. Kreider T, Anthony RM, Urban JF Jr, Gause WC. Alternatively activated macrophages in helminth infections. Curr Opin Immunol. 2007;19(4):448-453. (Pubitemid 47299196)
50. Van Ginderachter JA, et al. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006;211(6-8):487-501.
51. McKenzie GJ, Bancroft A, Grencis RK, McKenzie AN. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol. 1998;8(6):339-342. (Pubitemid 28159120)
52. Allen SR, et al. Effect of rotavirus strain on the murine model of biliary atresia. J Virol. 2007;81(4):1671-1679. (Pubitemid 46214442)
53. Maruyama T, et al. Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3. Nat Immunol. 2011;12(1):86-95.